Roble Belko & Company’s GE HealthCare GEHC Stock Holding History

Roble Belko & Company’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32K	Hold	497	–	–	﹤0.01%	240
2026 Q1	$35K	Buy	497 +181	+57%	+$14.3K	﹤0.01%	231
2025 Q4	$26K	Buy	316 +299	+1,759%	+$23.3K	﹤0.01%	250
2025 Q3	$1K	Hold	17	–	–	﹤0.01%	389
2025 Q2	$1K	Hold	17	–	–	﹤0.01%	370
2025 Q1	$1K	Sell	17 -30	-64%	-$2.58K	﹤0.01%	357
2024 Q4	$4K	Buy	47 +9	+24%	+$765	﹤0.01%	285
2024 Q3	$4K	Buy	38 +30	+375%	+$2.52K	﹤0.01%	267
2024 Q2	$1K	Hold	8	–	–	﹤0.01%	304
2024 Q1	$1K	Hold	8	–	–	﹤0.01%	299
2023 Q4	$1K	Hold	8	–	–	﹤0.01%	300
2023 Q3	$1K	Hold	8	–	–	﹤0.01%	271
2023 Q2	$1K	Hold	8	–	–	﹤0.01%	273
2023 Q1	$1K	Buy	+8	New	+$571	﹤0.01%	275

Other funds holding GEHC

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Roble Belko & Company's GEHC Position: Q2 2026 in Review

Roble Belko & Company held its GE HealthCare (GEHC) position steady in Q2 2026 at 497 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #240.

Roble Belko & Company first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $35K in Q1 2026. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

Roble Belko & Company held 497 shares of GE HealthCare worth $32K as of Q2 2026.
Roble Belko & Company left its GE HealthCare share count unchanged in Q2 2026.
GE HealthCare made up ﹤0.01% of Roble Belko & Company's portfolio in Q2 2026, its #240 holding.
Roble Belko & Company first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
Roble Belko & Company's GE HealthCare position peaked at $35K in Q1 2026.
1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.